New Drugs Could Wipe out Age-Related Diseases in One Sweep

Aging may cease to be a daunting prospect in the near future, scientists at the prestigious Mayo Clinic believe. This optimistic forecast is propelled by a seemingly new kind of drug which could target several age-related diseases at once.

Senolytic drugs, as they have been dubbed among the scientific community, target a specific group of cells called senescent cells, which play a crucial part in the process of aging. According to scientists, they duplicate instead of dividing, and they release toxic substances that actually damage or kill healthy cells.

A buildup of these harmful cells occurs with age, and according to the information gathered by researchers thus far, that build up may contribute to the development of several age-related conditions. In fact, these cells have been linked to some of the most fatal and debilitating diseases known to man, such as cancer, dementia, osteoporosis, arthritis and heart disease.

The good news delivered by the Mayo Clinic study is that the aforementioned senolytic drugs can cause a process that essentially leads to the programmed and controlled death of the harmful cells. This is a very promising prospect seeing as being able to kill these cells allows doctors and scientists to control and even prevent their accumulation.

The current research was conducted and published by the same team who first developed the drugs, but they aren’t the only ones looking into this particular subject. A different study not only corroborated their findings, but also found that the senolytic drugs, which are still under development, are capable of erasing only the harmful cells, reducing the risk of adverse effects or subsequent health problems.

The drugs have only been tested on animal models so far, but the results are quite promising, as they have been found to be very effective. Human trials need to be performed, however, in order to ascertain whether the drugs would behave the same way and show similar results in human beings.

If proven effective, senolytic drugs could start a revolution in the medical field, as they would certainly help delay the progression of age-related diseases and could even have the potential to prevent them from developing in the future.

Researchers expect to be able to share some information about the behavior of the potentially revolutionary drugs in relation to the human body sooner rather than later. In fact, the current timeframe for such trials and the publication of the resulting findings is between one and two years from now.

Meanwhile, each of the aforementioned age-related diseases need to be treated separately, using established courses of treatment that in many cases don’t work as effectively as we all would wish.